Silverback Therapeutics Axes Lead Immuno-Oncology Candidates, Lays Off 27% Workforce
Silverback Therapeutics Inc (NASDAQ:SBTX) undertakes “strategic realignment,” revealing it would drop its two lead cancer programs and lays off more than…
JonesTrading Downgrades Silverback Therapeutics to Hold
JonesTrading analyst Soumit Roy downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Hold.
HC Wainwright & Co. Downgrades Silverback Therapeutics to Neutral
HC Wainwright & Co. analyst Edward White downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Neutral.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Silverback Therapeutics Q3 EPS $(0.65) Up From $(11.97) YoY
Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.65) per share. This is a 94.57 percent increase over losses of $(11.97) per share from the same period last year.